16
Participants
Start Date
January 31, 2006
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Omega 3 Fatty Acids
The study medication will consist of combined EPA/DHA with a ratio of 2:1. Dosage will be titrated based on clinical response and side effects. The initial dose will be 1.2g/d. This will be increased gradually by 0.6 per 2 weeks to a possible maximum daily dose of 3.6 g/d. Patients will have to remain on a dose for 2 weeks to provide the opportunity to assess clinical response at any one dose. The total duration of the intervention will be 10 weeks.
Corn oil
The dosage will correspond to the titration schedule of the Omega-3 Fatty Acid experimental treatment. Placebo (corn oil) and omega-3FA capsules will be identical in color and smell.
Icahn School of Medicine at Mount Sinai, New York
National Center for Complementary and Integrative Health (NCCIH)
NIH
Icahn School of Medicine at Mount Sinai
OTHER